Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.
Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS. Prabhu JS, et al. Among authors: anupama ce. Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011. Epub 2017 Jul 11. Transl Oncol. 2017. PMID: 28704710 Free PMC article.
Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.
Rajarajan S, Korlimarla A, Alexander A, Anupama CE, Ramesh R, Srinath BS, Sridhar TS, Prabhu JS. Rajarajan S, et al. Among authors: anupama ce. Front Endocrinol (Lausanne). 2021 Jun 21;12:679756. doi: 10.3389/fendo.2021.679756. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34234742 Free PMC article.
An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers.
Rajarajan S, Snijesh VP, Anupama CE, Nair MG, Mavatkar AD, Naidu CM, Patil S, Nimbalkar VP, Alexander A, Pillai M, Jolly MK, Sabarinathan R, Ramesh RS, Bs S, Prabhu JS. Rajarajan S, et al. Among authors: anupama ce. Transl Oncol. 2023 Nov;37:101761. doi: 10.1016/j.tranon.2023.101761. Epub 2023 Aug 19. Transl Oncol. 2023. PMID: 37603927 Free PMC article.
Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes.
Snijesh VP, Nimbalkar VP, Patil S, Rajarajan S, Anupama CE, Mahalakshmi S, Alexander A, Soundharya R, Ramesh R, Srinath BS, Jolly MK, Prabhu JS. Snijesh VP, et al. Among authors: anupama ce. Transl Oncol. 2024 Jul;45:101957. doi: 10.1016/j.tranon.2024.101957. Epub 2024 Apr 20. Transl Oncol. 2024. PMID: 38643748 Free PMC article.
BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer.
Patil A, Patil S, Anupama CE, Rajarajan S, Nimbalkar VP, Amirtham U, Champaka G, Suma MN, Patil GV, Nargund A, Pallavi VR, Jacob L, Premalatha CS, Prabhu JS. Patil A, et al. Among authors: anupama ce. J Obstet Gynaecol Res. 2023 Dec;49(12):2875-2882. doi: 10.1111/jog.15796. Epub 2023 Sep 22. J Obstet Gynaecol Res. 2023. PMID: 37737055
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS. Desai K, et al. Among authors: ce a. Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028. Tumour Biol. 2017. PMID: 28349782 Free article.